FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801681757> ?p ?o ?g. }

• W2801681757 endingPage "e0196368" @default.
• W2801681757 startingPage "e0196368" @default.
• W2801681757 abstract "Rheumatoid arthritis (RA) and diabetes mellitus (DM) are associated with inflammation. We tried to investigate the influence of tumor necrosis factor inhibitors (TNFi) and tocilizumab (TCZ) on the glucose metabolism of RA patients. RA patients in whom treatment with TNFi or TCZ was initiated from 2008 to 2015 were studied based on their medical records. We analyzed patients whose glycosylated hemoglobin (HbA1c) levels were measured both before and 3 months after the initiation of these biologic agents. The association between HbA1c reduction and the treatment was evaluated. From 971 cases treated with these biologic agents, 221 cases whose medical records of HbA1c were available, were included (TNFi, n = 154; TCZ, n = 67). Both the TNFi and TCZ groups had significantly lower HbA1c values at 1 month and 3 months after the initiation of treatment (TNFi, p<0.001; TCZ, p<0.001). Although the pretreatment HbA1c values did not differ (TNFi, 6.2%; TCZ, 6.2%; p = 0.532), the 3-month treatment HbA1c values were lower (TNFi, 6.1%; TCZ, 5.8%; p = 0.010) and the changes in HbA1c (ΔHbA1c) were greater (TNFi, 0.1%; TCZ, 0.4%; p<0.001) in the TCZ group. The reduction of HbA1c—defined by the achievement of a ΔHbA1c of ≥0.5%—was associated with baseline diagnosis of diabetes mellitus, baseline diabetes treatment, hospitalization, medical change during the observation period, and TCZ. In the multivariate logistic regression analysis, TCZ was associated with the reduction of HbA1c in comparison to TNFi (adjusted OR = 5.59, 95% CI = 2.56–12.2; p<0.001). The HbA1c levels in RA patients were significantly lower after the initiation of TNFi or TCZ. Our study suggests that TCZ decreases the HbA1c levels in RA patients to a greater extent than TNFi." @default.
• W2801681757 created "2018-05-17" @default.
• W2801681757 creator A5000601871 @default.
• W2801681757 creator A5013618903 @default.
• W2801681757 creator A5016202108 @default.
• W2801681757 creator A5024581419 @default.
• W2801681757 creator A5026278665 @default.
• W2801681757 creator A5030740263 @default.
• W2801681757 creator A5032454512 @default.
• W2801681757 creator A5040535740 @default.
• W2801681757 creator A5044665470 @default.
• W2801681757 creator A5064060072 @default.
• W2801681757 creator A5077117032 @default.
• W2801681757 creator A5077232803 @default.
• W2801681757 creator A5082580465 @default.
• W2801681757 date "2018-04-25" @default.
• W2801681757 modified "2023-09-29" @default.
• W2801681757 title "Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study" @default.
• W2801681757 cites W1599172961 @default.
• W2801681757 cites W1629736006 @default.
• W2801681757 cites W1899262884 @default.
• W2801681757 cites W1974373780 @default.
• W2801681757 cites W1977476168 @default.
• W2801681757 cites W1990795149 @default.
• W2801681757 cites W1992808043 @default.
• W2801681757 cites W1997363583 @default.
• W2801681757 cites W2015410646 @default.
• W2801681757 cites W2018135697 @default.
• W2801681757 cites W2032658955 @default.
• W2801681757 cites W2037882607 @default.
• W2801681757 cites W2040901874 @default.
• W2801681757 cites W2041499523 @default.
• W2801681757 cites W2049628763 @default.
• W2801681757 cites W2055138591 @default.
• W2801681757 cites W2064938665 @default.
• W2801681757 cites W2071073097 @default.
• W2801681757 cites W2072781226 @default.
• W2801681757 cites W2074266524 @default.
• W2801681757 cites W2074685860 @default.
• W2801681757 cites W2076251313 @default.
• W2801681757 cites W2095670171 @default.
• W2801681757 cites W2097395605 @default.
• W2801681757 cites W2108892812 @default.
• W2801681757 cites W2120682972 @default.
• W2801681757 cites W2128005370 @default.
• W2801681757 cites W2131517206 @default.
• W2801681757 cites W2139957955 @default.
• W2801681757 cites W2140163728 @default.
• W2801681757 cites W2143727405 @default.
• W2801681757 cites W2146248479 @default.
• W2801681757 cites W2149569832 @default.
• W2801681757 cites W2150367899 @default.
• W2801681757 cites W2150561315 @default.
• W2801681757 cites W2153853625 @default.
• W2801681757 cites W2155824086 @default.
• W2801681757 cites W2156166356 @default.
• W2801681757 cites W2157856313 @default.
• W2801681757 cites W2168474283 @default.
• W2801681757 cites W2170973130 @default.
• W2801681757 cites W2273446805 @default.
• W2801681757 cites W2278473836 @default.
• W2801681757 cites W2343601477 @default.
• W2801681757 cites W2411826498 @default.
• W2801681757 cites W2412569576 @default.
• W2801681757 cites W2510966451 @default.
• W2801681757 cites W2549343671 @default.
• W2801681757 cites W2591643981 @default.
• W2801681757 cites W65358577 @default.
• W2801681757 doi "https://doi.org/10.1371/journal.pone.0196368" @default.
• W2801681757 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5918963" @default.
• W2801681757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29694426" @default.
• W2801681757 hasPublicationYear "2018" @default.
• W2801681757 type Work @default.
• W2801681757 sameAs 2801681757 @default.
• W2801681757 citedByCount "39" @default.
• W2801681757 countsByYear W28016817572019 @default.
• W2801681757 countsByYear W28016817572020 @default.
• W2801681757 countsByYear W28016817572021 @default.
• W2801681757 countsByYear W28016817572022 @default.
• W2801681757 countsByYear W28016817572023 @default.
• W2801681757 crossrefType "journal-article" @default.
• W2801681757 hasAuthorship W2801681757A5000601871 @default.
• W2801681757 hasAuthorship W2801681757A5013618903 @default.
• W2801681757 hasAuthorship W2801681757A5016202108 @default.
• W2801681757 hasAuthorship W2801681757A5024581419 @default.
• W2801681757 hasAuthorship W2801681757A5026278665 @default.
• W2801681757 hasAuthorship W2801681757A5030740263 @default.
• W2801681757 hasAuthorship W2801681757A5032454512 @default.
• W2801681757 hasAuthorship W2801681757A5040535740 @default.
• W2801681757 hasAuthorship W2801681757A5044665470 @default.
• W2801681757 hasAuthorship W2801681757A5064060072 @default.
• W2801681757 hasAuthorship W2801681757A5077117032 @default.
• W2801681757 hasAuthorship W2801681757A5077232803 @default.
• W2801681757 hasAuthorship W2801681757A5082580465 @default.
• W2801681757 hasBestOaLocation W28016817571 @default.
• W2801681757 hasConcept C126322002 @default.
• W2801681757 hasConcept C134018914 @default.
• W2801681757 hasConcept C2777178219 @default.

• next